MIRA INFORM REPORT

 

 

Report Date :

24.01.2007

 

IDENTIFICATION DETAILS

 

Name :

CENTAUR CHEMICALS PRIVATE LIMITED

 

 

Registered Office :

Shantinagar, Vakola, Santacruz (East), Mumbai – 400055, India 

 

 

Country :

India

 

 

Financials (as on) :

31.03.2006

 

 

Date of Incorporation :

19.11.1981

 

 

Com. Reg. No.:

11-25661

 

 

CIN No.:

[Company Identification No.]

U24100MH1981PTC025661

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMC01322G

 

 

PAN No.:

[Permanent Account No.]

AAACC0443Q

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

The subject is engaged in the business of manufacture, deal, distribute, buy, sell, exchange of fine chemicals, chemical intermediates, drug intermediates, medical and herbal extracts, synthetic organic, inorganic chemicals, distilled water, pharmaceutical medicines in the form of tablets capsules granules, injections, syrups or any other suitable form.  

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD750000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed company having satisfactory track. Directors are reported as experienced and respectable businessmen. Trade relations are reported as fair. Business is active. Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

LOCATIONS

 

Registered Office :

Shantinagar, Vakola, Santacruz (East), Mumbai – 400055, India 

Tel. No.:

91-22-56499100

Fax No.:

91-22-56499108 / 112

E-Mail :

export@centaurchem.com

Website :

http://www.centaurchem.com

 

DIRECTORS

 

Name :

Mr Deepak Sadanand S

Designation :

Director

Address :

Plot No 8/A, Green Valiey, Chogma Road, Pilrne Bardez, Goa

Date of Birth/Age :

20.08.1949

Date of Appointment :

06.02.2001

 

 

Name :

Mr Govind Guno

Designation :

Director

Address:

Kedar Apartment, Bhandara Gali, Off L J Road, Mumbai

Date of Appointment :

06.02.2001

 

MAJOR SHAREHOLDERS

 

Names of Shareholders

 

No. of Shares

Mr Shivanand Dattatraya Sawant

 

5820

Mr Jagdish Marutio Nadkarani

 

60

Mr Shrikant Dattatraya Sawant

 

 

Mr Anil Mahadev Naik

 

150

Ms Smita Abhaykumar Phal

 

4410

Ms Supriya Shivanand Sawant

 

 

Ms Rakhi Shridhar Kadam

 

5964

Ms veena Shivanand Kadam

 

360

Mr Sudhakar Keshav Rangnekar

 

 

Ms Rekha Gopinath Sawant

 

210

Mr Gopinath Dattatraya Sawant

 

210

Ms Sheela Shrikant Sawant

 

 

Ms Sudha Manohar Padgonkar

Mr Millind Manohar Padgonkar

 

1500

Mrs Geeta Ramesh Powar

 

60

Mr Aswin Shrikant Sawant

Ms Sheela Shrikant Sawant

 

 

Mr Tushar Shrikant Sawant

Ms Sheela Shrikant Sawant

 

582

Ms Sumitra Mohan Parulkar

 

10500

Mr Shivanand Dattatraya Sawant

Ms Veena Shivanand Sawant

 

 

Ms Veena Shivanand Sawant

Mr Shivanand Dattatraya Sawant

 

6054

Ms Smita Abhaykumar Phal

Ms Veena Shivanand Sawant

 

4554

Ms Rakhi Shridhar Kadam

Ms Veena Shivanand Sawant

 

 

Ms Supriya Shivanand Sawant

Ms Veena Shivanand Sawant

 

4554

Mr Shrikant Dattatraya Sawant

Ms Sheela Shrikant Sawant

 

9648

Ms Sheela Shrikant Sawant

Mr Shrikant Dattatraya Sawant

 

 

MrAnil Mahadev Naik

Ms Deepa Anilkumar Naik

 

2850

Mr Sudhakar Keshav Rangnekar

Ms Usha Sudhkar Rangnekar

 

1320

Mr Gopinath Dattatraya Sawant

Ms Rekha Gopinath Sawant

 

 

Mr Sachin Ramesh Powar

 

540

 

 

Category of Shareholders

 

Percentage of Holding

Directors or relatives of director

 

81.00

Other top 50 share holder

 

19.00

Total

 

100.00

 

BUSINESS DETAILS

 

Line of Business :

The subject is engaged in the business of manufacture, deal, distribute, buy, sell, exchange of fine chemicals, chemical intermediates, drug intermediates, medical and herbal extracts, synthetic organic, inorganic chemicals, distilled water, pharmaceutical medicines in the form of tablets capsules granules, injections, syrups or any other suitable form.  

 

 

Products :

The subject has been able to carve a niche as India's leading manufacturer and exporter of APIs based on intellectual strength, core competence and a right vision. This vision has translated into Centaur being the first in India to manufacture Clobazam, Clonazepam, Melitracen, Metolazone, Nortriptyline, Oxazepam, Zaleplon, Zolpidem and Zopiclone bulk actives.

 

Current API comprises of

·          Alprazolam

·          Brimonidine Tartrate

·          Chlordiazepoxide

·          Clobazam

·          Diazepam

·          Fluphenazine HCI

·          Melitracen HCI

·          Benzydamine HCI

·          Bromazepam

·          Clonazepam

·          Clorazepate Dapotassium

·          Flupentixol Dhihydrochloride

·          Lorazepam

·          Methvi Phenidate HCI

 

 

PRODUCTION STATUS

 

Particulars

Unit

 

Installed Capacity

Actual Production

Bulk drugs and drug Intermediates

Kilos

 

12500

(5000)

10894

(10661)

 

GENERAL INFORMATION

 

 

 

Bankers :

  • State bank of India

             Vile Parle, commercial Branch, Mumbai – 400057

 

  • Maharashtra State Financial Corporation

            Thane Demand and Diu Regional Office, Office Complex               Building, 6th Floor, Wagie Estate, MIDC, Thane (West)

 

Banking Relations :

Satisfactory

 

 

Auditors :

A K Dhere

Chartered Accountants

Address:

Arunoday Society, Ground Floor, Subhash Road, Vile Parle, Mumbai – 400057, Maharashtra

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

100,000

Equity Shares

Rs 100/- each

Rs 10.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

90,000

Equity Shares

Rs 100/- each

Rs 9.000 Millions

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2006

31.03.2005

31.03.2004

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

9.000

9.000

9.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

187.774

184.572

182.525

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

196.774

193.572

191.525

LOAN FUNDS

 

 

 

1] Secured Loans

72.335

67.569

36.558

2] Unsecured Loans

47.920

49.319

0.785

TOTAL BORROWING

120.255

116.888

37.343

DEFERRED TAX LIABILITIES

0.000

0.000

13.239

 

 

 

 

TOTAL

317.029

310.460

242.105

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

204.666

183.182

69.064

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.001

2.424

0.001

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

Inventories

54.308

61.186

75.162

Sundry Debtors

42.727

39.772

31.737

Cash & Bank Balances

19.135

17.782

55.677

Other Current Assets

0.000

0.000

0.000

Loans & Advances

103.146

108.208

130.866

Total Current Assets

219.316

226.948

293.442

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

Current Liabilities

39.339

38.765

120.401

 

Provisions

67.615

63.330

Total Current Liabilities

106.954

102.095

120.401

Net Current Assets

112.362

124.853

173.041

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

317.029

310.459

242.105

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2006

31.03.2005

31.03.2004

Sales Turnover [including other income]

231.580

190.388

246.830

 

 

 

 

Profit/(Loss) Before Tax

27.849

17.671

73.359

Provision for Taxation

16.874

12.544

42.680

Profit/(Loss) After Tax

10.975

5.127

30.679

 

 

 

 

Total Expenditure

203.731

172.717

173.471

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2006

31.03.2005

31.03.2004

PAT / Total Income

 

4.73

2.69

12.42

 

 

 

 

 

Net Profit Margin(PBT/Sales)

 

12.02

9.28

29.72

 

 

 

 

 

Return on Total Assets(PBT/Total Assets}

 

6.56

4.30

20.23

 

 

 

 

 

Return on Investment (ROI)(PBT/Networth)

 

0.14

0.09

0.38

 

 

 

 

 

Debt Equity Ratio(Total Liability/Networth)

 

1.15

1.13

0.82

 

 

 

 

 

Current Ratio(Current Asset/Current Liability)

 

2.05

2.22

2.43

 

LOCAL AGENCY FURTHER INFORMATION

 

India’s largest manufacturer and exporter of psychotropic APIs

 

Centaur, with a strong focus, has built strengths across their API, intermediates and exports business. We are now strategically poised to capitalize on the emerging opportunities in the domestic and international markets and deliver enhanced long term value.



Centaur is India's leading manufacturer and exporter of Psychotropic APIs with a footprint extending across more than 50

 

Manufacturing

 

Centaur leverages state-of-the-art manufacturing facility at Ambernath, near Mumbai, conforming to ISO 9001 : 2000 standards, to ensure quality products. As a future focused organization, we are building capacities and capabilities in India and across international geographies with strong demand potential.

Areas of specialization range from APIs and intermediates to process development and contract Manufacturing

 

Object of the company

 

The subject is engaged in the business of deal, distribute, buy, sell, exchange of chemicals, pharmaceuticals, medicines, dyes and colours used in food articles including food preparations, food supplements, confectionaries.

 

 

Name of the company

CENTAUR CHEMICALS PRIVATE LIMITED

Presented By

Mr Shrikant D Sawant

1) Date and description of instrument creating the change

1] General agreement for grant medium term advances to small scale industries and hypothecation of movables. Book debts and other assets

2] Ancillary agreement for medium term loan against pledge of movables machineries.

3] Memorandum of deposits of title deeds. (all document dated 24.01.2003 to constitute a single charge)

 

2) Amount secured by the charge/amount owing on the securities of charge

Rs 40.500 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

A] hypothecation of all movable plant and machinery of the company present and future more particularly described in the schedule ‘A’ and ‘B’ to the ancillary agreement for medium term loan

 

B] equitable mortgage of the following

1] factory building /  structures on plot no 75 admeasuring 2899 sq. meter situated at Chikloli MIDC, Ambernath

2] 3rd  and 4th floor admeasuring around 7200 Sq ft at shantinagar industrial estate, vakola, santacruz (east), Mumbai more particularly described in schedule to the deed details of securities more particularly specified in agreements dated 24.01.2003 as referred herein above under clause No 1

 

4) Gist of the terms and conditions and extent and operation of the charge.

Rate of interest 1.75% over minimum of 13.25% p.a.

Loan repayable in 18 quarterly instalments. Amount of first 17 installments Rs 2.225 Millions each and last 18th instalment of Rs 2.165 Millions commencing from 30th June, 2003

Margin : 33.60%

Charge to cover all outstanding sums, interests, costs, and charges payable by the company to the bank.

 

5) Name and Address and description of the person entitled to the charge.

State bank of India

Vile Parle, commercial Branch, Mumbai – 400057

6) Date  and brief description of instrument modifying the charge

NA

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

NA

 

 

Name of the company

CENTAUR CHEMICALS COMPANY PRIVATE LIMITED

Presented By

CENTAUR CHEMICALS COMPANY PRIVATE LIMITED

1) Date and description of instrument creating the change

No instrument was executed but an equitable mortgage was created by the company on the 08.09.1998

In favour of the Maharashtra state financial corporation by deposit of title deeds of the company’s flat bearing no 403 on the 4th floor in ‘A’ wing No 1, of padmavati complex, of plot no 8 and 24 of development scheme no 15 of ambernath and bearing CTS no 4717 to 4719 and 4723 to 4728, village kohop, within the village limits of ambernath municipal council, taluka ulhasnagar, district thane, described in the second schedule therto with Maharashtra state financial corporation with intent to create a security thereon by way of equitable mortgage pursuant to a resolution passed by the board of directors of the company on the 30.04.1998   

 

2) Amount secured by the charge/amount owing on the securities of charge

Rs 2.300 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

1] Mortgage by deposit of title deeds of flat bearing flat no 403 by way of second charge on flat on 4th floor, in a ‘A’ wing no 1 of padmavati complex, of plot no 8 and 24 of development scheme no 15 of ambernath and bearing CTS No 4717 to 4719 and 4723 to 4728 village kohop within the limits of ambernath municipal council taluka ulhasnagar district thane

 

4) Gist of the terms and conditions and extent and operation of the charge.

In consideration of the said loan of rs 2.300 millions from the corporation the company has mortgage the said flat owned by it in favour of the corporation as collateral security.

 

5) Name and Address and description of the person entitled to the charge.

Maharashtra State Financial Corporation

Thane Demand and Diu Regional Office, Office Complex Building, 6th Floor, Wagie Estate, MIDC, Thane (West)

6) Date  and brief description of instrument modifying the charge

N.A.

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

N.A.

 

 

Name of the company

CENTAUR CHEMICALS PRIVATE LIMITED

Presented By

Mr Shrikant D Sawant

1) Date and description of instrument creating the change

Mortgage deed dated 09.08.1994

2) Amount secured by the charge/amount owing on the securities of charge

Rs 6.750 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Plot No 75, chikhloli, MIDC, Ambernath

4) Gist of the terms and conditions and extent and operation of the charge.

As per RBI rules

5) Name and Address and description of the person entitled to the charge.

State Bank of India

6) Date  and brief description of instrument modifying the charge

N.A.

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

N.A.


CMT REPORT [Corruption, Money laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.21

UK Pound

1

Rs.87.48

Euro

1

Rs.57.23

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)                  Ownership background (20%)                         Payment record (10%)

Credit history (10%)                            Market trend (10%)                                             Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions